Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Artemis Therapeutics, Inc. | zk1719723.htm |
| EX-31.1 - EXHIBIT 31.1 - Artemis Therapeutics, Inc. | exhibit_31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Artemis Therapeutics, Inc. | exhibit_31-2.htm |
EXHIBIT 32.1
CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
In connection with the Annual Report of Artemis Therapeutics, Inc., a Delaware corporation (the “Company”) on Form 10-K for the year ended December 31, 2016 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers does hereby certify, that to the best of to such officer’s knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: March 31, 2017
|
/s/ Peter Payne
|
|
|
|
By: Peter Payne, Chief Executive Officer
|
|
|
Date: March 31, 2017
|
/s/ Chanan Morris
|
|
|
|
By: Chanan Morris, Chief Financial Officer
|
|